PROFOUND MEDICAL CORP. Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent
PROFOUND MEDICAL CORP. (PROF) reported Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent of 11.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes · last filed 2026-03-05
- PROFOUND MEDICAL CORP. effective income tax rate reconciliation, state and local income taxes, percent for fiscal 2025 was 11.00%, a 1.85% increase from fiscal 2024.
- PROFOUND MEDICAL CORP. effective income tax rate reconciliation, state and local income taxes, percent for fiscal 2024 was 10.80%, a 0.00% change from fiscal 2023.
- PROFOUND MEDICAL CORP. effective income tax rate reconciliation, state and local income taxes, percent for fiscal 2023 was 10.80%.
| Period end | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent 12 month |
|---|---|
| 2025-12-31 | 11.00% 10-K · filed 2026-03-05 |
| 2024-12-31 | 10.80% 10-K · filed 2026-03-05 |
| 2023-12-31 | 10.80% 10-K · filed 2025-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |